Jennifer Buell

Recent appearances

• 

  Advancing Allogeneic iNKT Therapy: MiNK CEO Jennifer Buell on AGENT-797 Results

  December 03, 2025 · 📺 OncoDaily TV

  In this OncoDaily episode, Dr. Amalya Sargsyan, Medical Oncologist and Vice President for Research & Intelligence at OncoDaily, speaks with Dr. Jennifer Buell, President & CEO of MiNK Therapeutics, a pioneer in allogeneic invariant natural killer T-cell (iNKT) therapies. 🎙️ WHAT YOU’LL LEARN IN THIS INTERVIEW ✅ What invariant natural killer T cells (iNKTs) are, and why they are different from NK cells or CAR-T cells ✅ How MiNK Therapeutics produces scalable, off-the-shelf, chemotherapy-free iNKT therapies (Agent-797) ✅ Why iNKT cells can survive and function in a hostile tumor microenvironme…

  Watch on YouTube ↗

• 

  Agenus Stakeholder Briefing-August 27, 2025

  August 29, 2025 · 📺 Agenus Bio

  Join Agenus for a powerful and timely Stakeholder Briefing that spotlights our latest progress in immuno-oncology and our mission to transform treatment outcomes for patients with difficult-to-treat cancers, especially metastatic colorectal cancer (mCRC). This webcast features unfiltered insights, patient stories, clinical data, and strategic updates.

  Watch on YouTube ↗

• 

  Agenus Stakeholder Webcast | Aug 27, 2025

  August 27, 2025 · 📺 Investing 101

  Agenus Stakeholder Webcast. Twitter -   / i101in   #earningscall #StockMarketNews #Q22025Results If you want us to remove your company's earnings call or any other conference call, please reach out to [email protected].

  Watch on YouTube ↗

• 

  Science Meets Creativity in Biotech Growth | Seuss+ Podcast Ep. 2 with Dr. Jennifer Buell

  April 22, 2025 · 📺 Seuss+ Life Science Consulting

  What happens when science meets creativity in biotech? In this episode of the Seuss+ Podcast, Seuss+ CEO and Co-Founder ...

  Watch on YouTube ↗

• 

  Your immunity is living medicine that can save lives, today. | Jennifer Buell | TEDxBoston

  April 13, 2022 · 📺 TEDx Talks

  Diseases of a defective immune system are prevalent and life altering. We can intervene by taking some of the most highly conserved and potent cells in immunity from a healthy donor and transplanting it into a recipient to help eliminate disease (cancer, infections, autoimmunity). Here's how. Biotech, Change, Health, Innovation, Science Dr. Jennifer Buell is the Chief Executive Officer at MiNK Therapeutics. She brings more than 25 years of biopharmaceutical experience, leading teams to advance discovery candidates through to clinical development to commercialization. She was previously Presid…

  Watch on YouTube ↗

• 

  Jennifer S. Buell, President & COO, Agenus - Datasite Interview

  January 08, 2021 · 📺 Datasite

  https://www.datasite.com/us/en/soluti... — A series of insightful videos from your peers and leaders in the Healthcare and Life Sciences sector. This series of videos will give you exclusive insights into the year ahead from some of the top minds in the space. Find out how COVID-19 impacted what they do and how they do it. Get their take on how the rules of the deal-making game have changed going forward. Learn more about how virtual data rooms for healthcare help to drive innovation with Datasite: https://www.datasite.com/us/en/resour... Visit https://datasite.force.com/datasiteas...…

  Watch on YouTube ↗

• 

  Agenus Inc AGEN CEO Garo Armen on Q4 2019 Results

  March 12, 2020 · 📺 Daily Earnings Calls

  Watch on YouTube ↗